Aibotics is an early-stage consumer robotics and smart home device company. Following a late 2024 acquisition of assets from Philon Labs, Aibotics pivoted from psychedelic therapy research to focus on two consumer hardware products. The first is the Phill Robot, an AI-powered home massage robot with a foldable arm that doubles as a bedside nightstand, designed as a personalized home wellness device. The second is the Milkyway, a smart refrigerator for breast milk storage that uses a vertical rotating system to organize bags by date and volume and connects to a smartphone app for temperature and inventory monitoring — sold in home and hospital configurations. Neither product is classified as a medical device. Aibotics intends to sell both products directly to consumers, with Milkyway also targeting hospitals and nursing facilities. The company is pre-revenue, and the Philon Labs acquisition was structured with up to $7M in additional Preferred Stock issuable to acquired employees over three years, contingent on revenue generated by those assets. Prior to this pivot, Aibotics was pursuing a role as a supply chain participant in psychedelic-assisted mental health therapy, specifically psilocybin, through a supply agreement with Canadian biotech HAVN Life Sciences. That strategy appears deprioritized but not formally abandoned. The company has a long history of name changes, reverse mergers, and strategic pivots dating back to its Nevada incorporation in 2000.